Rottendorf Pharma GmbH, Synthon B.V., Synthon Hispania S.L.

The medicine is used for the hormonal treatment of breast cancer in postmenopausal women. It may be used to prevent the recurrence of the disease, as preoperative or postoperative treatment (including after five years of tamoxifen use), as well as to prevent the spread of the tumor in patients with advanced breast cancer.

Dosage form: tablets, film-coated

ATC: L02BG04